2020 annual financial data

Corcept Therapeutics Incorporated 2020 Operating margin

Corcept Therapeutics Incorporated 2020 operating margin with verified reported…

Direct answer

Operating margin was 36.23%.

Operating income was 128,202,000 USD and net income was 106,011,000 USD.
Operating cash flow was 151,970,000 USD.

Get free Corcept Therapeutics Incorporated email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
353,874,000 USD
Operating income
128,202,000 USD
Net income
106,011,000 USD
Operating cash flow
151,970,000 USD